Literature DB >> 165668

Mechanisms of control for cAMP-dependent protein kinase from skeletal muscle.

J A Beavo, P J Bechtel, E G Krebs.   

Abstract

A number of properties of homogeneous cyclic 3',5'-AMP (cAMP)-dependent protein kinase from rabbit skeletal muscle were determined. The enzyme is shown to be a tetramer consisting of one regulatory subunit dimer and two catalytic subunit monomers. Skeletal muscle protein kinase interacts with cAMP and MgATP as illustrated in the following equilibrium expression: R2C2 - (MgATP)2 + 2 cAMP in equilibrium R2 - (cAMP)2 + 2C + 2 MgATP. MgATP is shown to decrease the affinity of the enzyme for cAMP and to be necessary for recombination of the subunits. The concentration of the enzyme in tissue relative to that of cAMP is high enough to influence kinetic parameters of the activation process by cAMP. The cumulative effects of MgATP and high enzyme concentration are to increase the apparent activation constant for cAMP so that in vivo the enzyme would not be highly activated under basal conditions but would be greatly stimulated by increases in cAMP concentration. As a result, it is not necessary to invoke the concept of compartmentalization of cAMP to explain how it could regulate protein kinase activity in vivo. Finally, data are presented which indicate that a possible function of the heat-stable protein inhibitor of cAMP-dependent protein kinases may be to suppress the activity of protein kinase due to basal concentrations of cAMP. As such, the inhibitor could indirectly change the amount of cAMP needed to allow expression of protein kinase activity.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 165668

Source DB:  PubMed          Journal:  Adv Cyclic Nucleotide Res        ISSN: 0084-5930


  21 in total

1.  In vivo and in vitro phosphorylation of rat liver fructose-1,6-bisphosphatase.

Authors:  J P Riou; T H Claus; D A Flockhart; J D Corbin; S J Pilkis
Journal:  Proc Natl Acad Sci U S A       Date:  1977-10       Impact factor: 11.205

2.  Modulation of cyclic AMP-dependent protein kinase by vasopressin and calcitonin in cultured porcine renal LLC-PK1 cells.

Authors:  D A Ausiello; D H Hall; J M Dayer
Journal:  Biochem J       Date:  1980-03-15       Impact factor: 3.857

3.  Studies of the mode of stimulation by external acidification and raising the internal free calcium concentration of the sodium efflux in barnacle muscle fibers.

Authors:  R Schultz; E E Bittar
Journal:  Pflugers Arch       Date:  1978-04-25       Impact factor: 3.657

4.  An active twenty-amino-acid-residue peptide derived from the inhibitor protein of the cyclic AMP-dependent protein kinase.

Authors:  H C Cheng; S M van Patten; A J Smith; D A Walsh
Journal:  Biochem J       Date:  1985-11-01       Impact factor: 3.857

5.  Species-dependent isoenzyme subtypes of membrane-bound cyclic AMP-dependent protein kinase in highly purified cardiac sarcolemma.

Authors:  J G Church; J B Derdemezi; S Yuan; A K Sen
Journal:  Biochem J       Date:  1986-09-01       Impact factor: 3.857

6.  Cyclic AMP binding proteins and cyclic AMP-dependent protein kinase from Blastocladiella emersonii.

Authors:  P M Silverman
Journal:  J Bacteriol       Date:  1978-09       Impact factor: 3.490

7.  Isozymic forms of rat brain Ca2+-activated and phospholipid-dependent protein kinase.

Authors:  K P Huang; H Nakabayashi; F L Huang
Journal:  Proc Natl Acad Sci U S A       Date:  1986-11       Impact factor: 11.205

8.  Genetic characterization of a brain-specific form of the type I regulatory subunit of cAMP-dependent protein kinase.

Authors:  C H Clegg; G G Cadd; G S McKnight
Journal:  Proc Natl Acad Sci U S A       Date:  1988-06       Impact factor: 11.205

9.  Radioimmunoassay of bovine heart protein kinase.

Authors:  N Fleischer; O M Rosen; M Reichlin
Journal:  Proc Natl Acad Sci U S A       Date:  1976-01       Impact factor: 11.205

10.  Primary structure of the regulatory subunit of type II cAMP-dependent protein kinase from bovine cardiac muscle.

Authors:  K Takio; S B Smith; E G Krebs; K A Walsh; K Titani
Journal:  Proc Natl Acad Sci U S A       Date:  1982-04       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.